Swedish Orphan (Sweden) Profile

SEK 1.55  0.82%

Swedish Orphan Summary

Swedish Orphan Biovitrum AB (SOBI) is traded on Stockholm Stock Exchange in Sweden. It is located in Tomtebodav?gen 23A and employs 816 people. The company currently falls under 'Large-Cap' category with current market capitalization of 48.28 B. Swedish Orphan Biovitrum AB operates under Healthcare sector and is part of Medical Laboratories and Research industry. This company has 269.26 M outstanding shares. SWE ORPHAN BIOVIT has accumulated about 1.75 B in cash with 1.29 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.5.
Check Swedish Orphan Probability Of Bankruptcy

Target Price Odds Analysis

Odds Below 190.0HorizonTargetOdds Above 190.0
?%30 days 190.00 ?%
Based on normal probability distribution, the odds of Swedish Orphan to move above current price in 30 days from now is about 0.0% (This Swedish Orphan Biovitrum AB probability density function shows the probability of Swedish Orphan Stock to fall within a particular range of prices over 30 days) .

Key Fundamentals

Swedish Orphan Against Markets

Current Ratings

Swedish Orphan 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
Equity ratings for Swedish Orphan Biovitrum AB are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Swedish Orphan Biovitrum AB , an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haemophilia, inflammation, and genetic and lysosomal diseases. Swedish Orphan Biovitrum AB is headquartered in Solna, Sweden. Swedish Orphan operates under Pharmaceuticals And Biosciences classification in Sweden and traded on Stockholm Stock Exchange. It employs 816 people. more
NameSwedish Orphan Biovitrum AB
Macroaxis Advice
Healthcare, Pharmaceuticals And Biosciences
InstrumentSweden Stock View All
Business AddressTomtebodav?gen 23A
ExchangeStockholm Stock Exchange
IndustryMedical Laboratories and Research
Contact Number46 86 97 20 00
CurrencySEK - Swedish Kronor

Current Sentiment - SOBI

Swedish Orphan Biovi Investor Sentiment
Macroaxis portfolio users are evenly split in their outlook on investing in Swedish Orphan Biovitrum AB. What is your outlook on investing in Swedish Orphan Biovitrum AB? Are you bullish or bearish?
50% Bullish
50% Bearish

Diversify with Swedish Orphan Biovitrum AB

Build Optimal Portfolios
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Swedish Orphan Biovitrum AB to your portfolio
Also please take a look at World Market Map. Please also try Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.